Cost-effectiveness of semi-annual surveillance for hepatocellular carcinoma in cirrhotic patients of the Italian Liver Cancer population.
about
Management of treatment-naïve chronic hepatitis C genotype 1 patients: a cost-effectiveness analysis of treatment options.Delayed Diagnosis of HCC with Chronic Alcoholic Liver Disease.Prospective screening increases the detection of potentially curable hepatocellular carcinoma: results in 8,900 high-risk patients.Surveillance for early diagnosis of hepatocellular carcinoma: how best to do it?Healthcare Costs Related to Treatment of Hepatocellular Carcinoma Among Veterans With Cirrhosis in the United States.Transarterial Embolization and Percutaneous Ethanol Injection as an Effective Bridge Therapy before Liver Transplantation for Hepatitis C-Related Hepatocellular Carcinoma.Effective but costly: How to tackle difficult trade-offs in evaluating health improving technologies in liver diseases.Mortality from cirrhosis and hepatocellular carcinoma in Western Europe over the last 40 years.Lack of evidence that adherence to standard of care therapy improves survival in subjects with hepatocellular carcinoma in clinical practice.Years of life that could be saved from prevention of hepatocellular carcinoma.Hospitalized Patients with Cirrhosis Should Be Screened for Clostridium difficile Colitis.Adequate interval for hepatocellular carcinoma surveillance.The Diagnostic Performance of Liver MRI without Intravenous Contrast for Detecting Hepatocellular Carcinoma: A Case-Controlled Feasibility Study.Hepatocellular carcinoma
P2860
Q35900280-ECBD0856-AD2B-4010-8611-A5B21C9249F3Q37140682-C09E98F9-F7DA-4C6C-B07F-99CAF577E969Q37350320-9B1C0914-38EB-41CA-9BDF-183EF658E18DQ37408912-A870453D-80D8-4F40-BF92-4D0FA7576483Q38399579-76BC5387-C220-4964-8101-EF318645E4CAQ38714620-C0751E31-C5C0-4694-9191-6950E9B9D497Q38755073-A0D1B0EE-F6A9-43B6-88D4-7A40500E407FQ39006162-7548DA8B-2549-435F-9EE6-5E656D80CBADQ39035163-D256C00F-8B5C-4624-BE70-E4181EF095FCQ40007128-88D9ED2D-AC00-4222-9277-B3BA97F4E700Q40926881-5CEB51BC-B0DE-49F2-8B83-0FEF284BE970Q45788894-4FB2BDAD-D330-4A9A-8F3C-229F65E4662DQ55424498-2FE22FFB-AE9B-4B6C-8EE0-6899770C365FQ57756376-F284DD76-AE0E-4D4B-898F-61950661EAD3
P2860
Cost-effectiveness of semi-annual surveillance for hepatocellular carcinoma in cirrhotic patients of the Italian Liver Cancer population.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
Cost-effectiveness of semi-ann ...... alian Liver Cancer population.
@en
Cost-effectiveness of semi-ann ...... alian Liver Cancer population.
@nl
type
label
Cost-effectiveness of semi-ann ...... alian Liver Cancer population.
@en
Cost-effectiveness of semi-ann ...... alian Liver Cancer population.
@nl
prefLabel
Cost-effectiveness of semi-ann ...... alian Liver Cancer population.
@en
Cost-effectiveness of semi-ann ...... alian Liver Cancer population.
@nl
P2093
P50
P1476
Cost-effectiveness of semi-ann ...... alian Liver Cancer population.
@en
P2093
Antonio Daniele Pinna
Eugenio Caturelli
Fabio Farinati
Franco Borzio
Franco Trevisani
Gianludovico Rapaccini
Italian Liver Cancer (ITA.LI.CA) Group
Luisa Benvegnù
Marco Zoli
Maria Anna Di Nolfo
P304
P356
10.1016/J.JHEP.2011.11.022
P577
2012-01-13T00:00:00Z